Natixis Advisors, L.P. Horizon Therapeutics Public LTD CO Transaction History

Natixis Advisors, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $12 Million - $12.7 Million	-111,900 Reduced 81.58%	25,267 $2.76 Million
Q4 2022 Jan 27, 2023	SELL	$62.39 - $113.8 $1.44 Million - $2.63 Million	-23,148 Reduced 14.44%	137,167 $15.6 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $3.91 Million - $5.63 Million	-66,445 Reduced 29.3%	160,315 $9.92 Million
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $180,079 - $263,904	-2,268 Reduced 0.99%	226,760 $18.1 Million
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $4.55 Million - $5.78 Million	52,675 Added 29.87%	229,028 $24.1 Million

Q4 2021 Feb 08, 2022	BUY	$98.56 - $119.91 $669,025 - $813,949	6,788 Added 4.0%	176,353 $19 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $3.04 Million - $3.65 Million	33,063 Added 24.22%	169,565 $18.6 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $5.05 Million - $5.62 Million	58,577 Added 75.17%	136,502 $12.8 Million
Q1 2021 May 05, 2021	BUY	$71.83 - $95.48 $811,607 - $1.08 Million	11,299 Added 16.96%	77,925 $7.17 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $124,151 - $156,374	1,853 Added 2.86%	66,626 $4.87 Million
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $26,952 - $39,005	-488 Reduced 0.75%	64,773 $5.03 Million
Q2 2020 Aug 11, 2020	BUY	$30.2 - $56.98 $1.97 Million - $3.72 Million	65,261 New	65,261 $3.63 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.